![](/images/introroll.png)
High efficiency placenta MSC Injection
-- Type 2 Diabetes
Patients: 10 patients with different degrees of type 2 diabetes use different insulin measurements every day
Intervention: intravenous injection of different doses of stem cells according to the situation of different patients.
Effects: the dosage of insulin was reduced by half a day in ten patients. No patients with fever, chills, liver function damage and other side effects, and renal function and cardiac function improved after injection.
Conclusion: no side effects such as fever, chills, liver function injury and rejection were found, and the renal function and cardiac function after infusion were improved. It is suggested that placental mesenchymal stem cell transplantation is a safe and effective method for the treatment of islet dysfunction in type 2 diabetes.
-- Critical Limb Ischemia
Diabetic complications -- autologous stem cells
Patients: 28 patients with severe limb ischemia with diabetes were randomly assigned to the autologous stem cell transplantation group and the conventional treatment control group, hereinafter referred to as the "transplant group" and the control group.
Intervention: the patient's autologous stem cells were injected into the ischemic limb of the patient through multiple intramuscular injection. All patients were followed up for at least 3 months.
Therapeutic outcome:
-
(1) At the end of the 3 month follow-up, the patients in the transplantation group significantly reduced the pain and ulcers of the lower extremities.
-
(2) Of the 18 limb ulcers, 14 cases healed completely (77.8%), while 18 of the control group only healed 7 cases (38.9%).
-
(3) The transplant group had no adverse reactions and no amputation, while 5 patients in the control group had to undergo lower limb amputation.
-
(4) Compared with the control group, the angiographic score of the transplantation group improved significantly.
Conclusion:
These results suggest that autologous stem cell transplantation is a simple, safe, effective and novel method for the treatment of limb ischemic complications caused by diabetes.
-- Aplastic anemia
Placenta mesenchymal stem cells treat sugar, urine, disease and feet.